Real-world First-line Serplulimab-based Immunochemotherapy for Extensive-stage Small Cell Lung Cancer
Clinical trial NCT06748495 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06748495
- Sponsor
- Hunan Cancer Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-02-05
- Primary completion
- 2024-12-30
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.